Island Pharmaceuticals Ltd Statistics
Want to see AU:ILA full AI Analyst Report?
Island Pharmaceuticals Ltd (ILA) Stock Statistics & Valuation Metrics
Total Valuation
Island Pharmaceuticals Ltd has a market cap or net worth of AUD 90.31M. The enterprise value is AUD 99.58M.
- Market Cap
- AUD 90.31M
- Enterprise Value
- AUD 99.58M
Share Statistics
Island Pharmaceuticals Ltd has 296,096,680 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 296,096,680
- Owned by Insiders
- 11.81%
- Owned by Institutions
- ―
Financial Efficiency
Island Pharmaceuticals Ltd’s return on equity (ROE) is -0.73 and return on invested capital (ROIC) is -76.69%.
- Return on Equity (ROE)
- -0.73
- Return on Assets (ROA)
- -0.70
- Return on Invested Capital (ROIC)
- -76.69%
- Return on Capital Employed (ROCE)
- -0.79
- Revenue Per Employee
- ―
- Profits Per Employee
- ―
- Employee Count
- 0
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Island Pharmaceuticals Ltd is -8.47. Island Pharmaceuticals Ltd’s PEG ratio is 0.18.
- PE Ratio
- -8.47
- PS Ratio
- 0.00
- PB Ratio
- 6.71
- Price to FCF
- -18.68
- Price to Operating Cash Flow
- -18.67
- PEG Ratio
- 0.18
Income Statement
In the last 12 months, Island Pharmaceuticals Ltd had revenue of 0 and earned -9.84M in profits. Earnings per share was -0.04.
- Revenue
- 0
- Gross Profit
- -105.29K
- Operating Income
- -10.62M
- Pretax Income
- -10.13M
- Net Income
- -9.84M
- EBITDA
- -10.51M
- Earnings Per Share (EPS)
- -0.04
Cash Flow
In the last 12 months, operating cash flow was -4.83M and capital expenditures -1, giving a free cash flow of -4.83M billion.
- Operating Cash Flow
- -4.83M
- Free Cash Flow
- -4.83M
- Free Cash Flow per Share
- -0.02
Dividends & Yields
Island Pharmaceuticals Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -5.35%
- Earnings Yield
- -10.91%
Stock Price Statistics
- Beta
- -0.71
- 52-Week Price Change
- -41.90%
- 50-Day Moving Average
- 0.36
- 200-Day Moving Average
- 0.39
- Relative Strength Index (RSI)
- 40.30
- Average Volume (3m)
- 197.86K
Important Dates
Island Pharmaceuticals Ltd upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 26, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Island Pharmaceuticals Ltd as a current ratio of 24.62, with Debt / Equity ratio of 0.00%
- Current Ratio
- 24.62
- Quick Ratio
- 24.62
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.22
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Island Pharmaceuticals Ltd has paid -282.66K in taxes.
- Income Tax
- -282.66K
- Effective Tax Rate
- 0.03
Enterprise Valuation
Island Pharmaceuticals Ltd EV to EBITDA ratio is -7.37, with an EV/FCF ratio of -16.02.
- EV to Sales
- 0.00
- EV to EBITDA
- -7.37
- EV to Free Cash Flow
- -16.02
- EV to Operating Cash Flow
- -16.02
Balance Sheet
Island Pharmaceuticals Ltd has AUD 12.87M in cash and marketable securities with AUD 0.00 in debt, giving a net cash position of AUD 12.87M billion.
- Cash & Marketable Securities
- AUD 12.87M
- Total Debt
- AUD 0.00
- Net Cash
- AUD 12.87M
- Net Cash Per Share
- AUD 0.04
- Tangible Book Value Per Share
- AUD 0.04
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Island Pharmaceuticals Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -59.29%
Scores
- Smart Score
- 1
- AI Score
- 42

